Within this group, MX1, as part of the Type I Interferon (I-IFN) pathway, was found to potentially monitor the expression of AP-1 TFs, suggesting a role of I-IFN in DS-associated dysfunction (Figs. 3 and 4). The gene discussed is FOS; the disease is Dravet syndrome.